Aaron L Schacht

CIK 1752460 · View on SEC EDGAR ↗

Insider

First SEC filing: March 3, 2021 · Latest: March 3, 2021

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 17 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

17 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
March 11, 2019 ELAN P 1,227 13,924 Direct +9.66% Acquired (price as of 2026-08-21)
Sept. 24, 2018 ELAN P 400 $24.00 $9,600 400 Direct Acquired 0.2% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Oct. 20, 2018 ELAN Non-Qualified Stock Option (Right-to-Buy) Elanco Animal Health Inc. Common Stock (21,086) $31.61 Oct. 20, 2028 21,086 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ELAN

President, Innovation, Regulatory and Business Development
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2021 $609,000 $1,859,028 $562,716 $1,087,226 $4,117,970
2020
2019 $434,167 $0 $2,101,855 $0 $270,920 $19,367 $2,826,309

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.